Altoida AG
Join us on our noble mission to better brain health
As a predictive digital biomarker company, Altoida, Inc. has developed technology using smart device sensors to measure cognition, function and motor skills. The innovation is based on three major pillars: (1) Active Digital Biomarkers, (2) Artificial Intelligence and (3) Augmented Reality. Altoida's Digital Neuro Signatures (DNS) is an FDA-cleared class II medical device, that collects data from the electronics sensors in the users device to analyze 748 proprietary digital biomarkers and provide an objective measurement of brain function across 11 neurocognitive domains and subdomains, (backed by DSM-5 criteria) and a novel Digital Neuro Signature score.
Only registered users have access to funding information.
Please log in or register to continue. Registration is free.
04.01.2024
Altoida’s study unveils encouraging results for Alzheimer’s Disease assessment (startupticker.ch)
25.10.2023
Positive clinical developments for three digital health startups (startupticker.ch)
12.06.2023
Key executive hires for seven startups (startupticker.ch)
20.09.2022
Applauses for Swiss Innovators (startupticker.ch)
03.08.2022
"If not you, then who?" — Interview with Maria Luisa Fuchs of Startup@HSG at the University of St. Gallen (venturelab.swiss)
Last Tweets
No Jobs
Videos
Altoida Patient Training Video
Dementia precaution should become as normal as going to the dentist | Ioannis Tarnanas | TEDxZurich
TOP 100 Swiss Startup Award
The TOP 100 Swiss Startup Ranking features the 100 most promising startups that are not older than five years and are selected by a jury of early-stage investors.
Venture Kick
Venture Kick supports potential entrepreneurs with start capital up to CHF 150'000 as well as hands-on execution support and access to a nationwide network of investors and experts in the startup field. Multiple times per year, 8 selected projects get the opportunity to present their business ideas in front of a panel. The 5 most promising projects enter the support process. After 9 months at the latest, the startups incorporate and enter the market. Since 2007, Venture Kick has invested over CHF 58 million in over 1111 projects.
HSG Spin-off
The University of St.Gallen issues a Spin-Off label under the supervision of the Center for Entrepreneurship. This label is meant to build and leverage the entrepreneurial community stemming from these breeding grounds. It awards entrepreneurship and innovation, credibility and trust, accountability and sustainability and is built on the knowledge transfer through this institution.
Altoida AG
Join us on our noble mission to better brain health
Website:
www.altoida.com/
Headquarter:
Luzern
Foundation Date:
May 2016
Technology:
- Medtech
Sectors:
- Medtech
- Neurology
- Patient monitoring
- Screening
Support received
